- Home
- BCAX vs ITIC Comparison
BCAX vs ITIC Comparison
Compare BCAX & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- ITIC
- Stock Information
- Founded
- BCAX 2018
- ITIC 1972
- Country
- BCAX United States
- ITIC United States
- Employees
- BCAX N/A
- ITIC N/A
- Industry
- BCAX
- ITIC Specialty Insurers
- Sector
- BCAX
- ITIC Finance
- Exchange
- BCAX NYSE
- ITIC Nasdaq
- Market Cap
- BCAX 541.0M
- ITIC 440.1M
- IPO Year
- BCAX 2024
- ITIC N/A
- Fundamental
- Price
- BCAX $10.53
- ITIC $210.28
- Analyst Decision
- BCAX Strong Buy
- ITIC
- Analyst Count
- BCAX 7
- ITIC 0
- Target Price
- BCAX $29.17
- ITIC N/A
- AVG Volume (30 Days)
- BCAX 329.8K
- ITIC 56.0K
- Earning Date
- BCAX 08-16-2025
- ITIC 08-12-2025
- Dividend Yield
- BCAX N/A
- ITIC 7.53%
- EPS Growth
- BCAX N/A
- ITIC 18.56
- EPS
- BCAX N/A
- ITIC 15.69
- Revenue
- BCAX N/A
- ITIC $261,197,999.00
- Revenue This Year
- BCAX N/A
- ITIC N/A
- Revenue Next Year
- BCAX N/A
- ITIC N/A
- P/E Ratio
- BCAX N/A
- ITIC $13.40
- Revenue Growth
- BCAX N/A
- ITIC 15.27
- 52 Week Low
- BCAX $7.80
- ITIC $189.45
- 52 Week High
- BCAX $28.09
- ITIC $290.40
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- ITIC 50.77
- Support Level
- BCAX N/A
- ITIC $200.95
- Resistance Level
- BCAX N/A
- ITIC $221.16
- Average True Range (ATR)
- BCAX 0.00
- ITIC 5.60
- MACD
- BCAX 0.00
- ITIC 1.04
- Stochastic Oscillator
- BCAX 0.00
- ITIC 50.55
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.